113 related articles for article (PubMed ID: 37146505)
21. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.
Steevens J; van den Brandt PA; Goldbohm RA; Schouten LJ
Gastroenterology; 2010 May; 138(5):1704-13. PubMed ID: 20006613
[TBL] [Abstract][Full Text] [Related]
22. Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study.
Schulpen M; Peeters PH; van den Brandt PA
Gastric Cancer; 2019 Jul; 22(4):663-674. PubMed ID: 30771119
[TBL] [Abstract][Full Text] [Related]
23. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
[TBL] [Abstract][Full Text] [Related]
24. Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype.
Okada M; Ishimura N; Mikami H; Okimoto E; Oshima N; Miyaoka Y; Fujishiro H; Ishihara S; Kinoshita Y
Esophagus; 2019 Jan; 16(1):98-106. PubMed ID: 30145681
[TBL] [Abstract][Full Text] [Related]
25. Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer.
Crumley AB; Going JJ; Hilmy M; Dutta S; Tannahill C; McKernan M; Edwards J; Stuart RC; McMillan DC
Ann Surg Oncol; 2011 Sep; 18(9):2604-12. PubMed ID: 21409484
[TBL] [Abstract][Full Text] [Related]
26. Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.
Cummings LC; Cooper GS
Cancer Detect Prev; 2008; 32(1):87-92. PubMed ID: 18406068
[TBL] [Abstract][Full Text] [Related]
27. Tislelizumab Plus Chemotherapy as First-line Treatment for Advanced Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma.
Xu J; Bai Y; Xu N; Li E; Wang B; Wang J; Li X; Wang X; Yuan X
Clin Cancer Res; 2020 Sep; 26(17):4542-4550. PubMed ID: 32561664
[TBL] [Abstract][Full Text] [Related]
28. Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Plazas JG; Arias-Martinez A; Lecumberri A; Martínez de Castro E; Custodio A; Cano JM; Hernandez R; Montes AF; Macias I; Pieras-Lopez A; Diez M; Visa L; Tocino RV; Lago NM; Limón ML; Gil M; Pimentel P; Mangas M; Granja M; Carnicero AM; Pérez CH; Gonzalez LG; Jimenez-Fonseca P; Carmona-Bayonas A
ESMO Open; 2022 Jun; 7(3):100514. PubMed ID: 35714478
[TBL] [Abstract][Full Text] [Related]
29. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
[TBL] [Abstract][Full Text] [Related]
30. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
Dikken JL; Lemmens VE; Wouters MW; Wijnhoven BP; Siersema PD; Nieuwenhuijzen GA; van Sandick JW; Cats A; Verheij M; Coebergh JW; van de Velde CJ
Eur J Cancer; 2012 Jul; 48(11):1624-32. PubMed ID: 22317953
[TBL] [Abstract][Full Text] [Related]
31. Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States.
Wang SM; Katki HA; Graubard BI; Kahle LL; Chaturvedi A; Matthews CE; Freedman ND; Abnet CC
Am J Gastroenterol; 2021 Sep; 116(9):1844-1852. PubMed ID: 34240714
[TBL] [Abstract][Full Text] [Related]
32. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
33. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
34. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
Probst A; Aust D; Märkl B; Anthuber M; Messmann H
Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
36. Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.
Jin Z; Holubek M; Sukov WR; Sattler CA; Wiktor AE; Jenkins RB; Wu TT; Yoon HH
Am J Clin Oncol; 2019 Feb; 42(2):190-195. PubMed ID: 30516569
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
Fuchs CS; Niedzwiecki D; Mamon HJ; Tepper JE; Ye X; Swanson RS; Enzinger PC; Haller DG; Dragovich T; Alberts SR; Bjarnason GA; Willett CG; Gunderson LL; Goldberg RM; Venook AP; Ilson D; O'Reilly E; Ciombor K; Berg DJ; Meyerhardt J; Mayer RJ
J Clin Oncol; 2017 Nov; 35(32):3671-3677. PubMed ID: 28976791
[TBL] [Abstract][Full Text] [Related]
38. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
Holmberg D; Ness-Jensen E; Mattsson F; Lagergren J
Int J Cancer; 2020 Jul; 147(1):93-99. PubMed ID: 31583704
[TBL] [Abstract][Full Text] [Related]
39. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
